Renal Tumours Of Non-Clear Cell Histology; 10 Years' Experience In A Specialized Centre.

Background: Non-clear cell renal cell carcinomas are uncommon renal tumours with diverse histologically and genetically defined entities. Due to limited clinical outcomes data, no standardized management approach can be offered to these patients. This study aimed to analyse outcomes of non clear cell renal cell carcinoma after surgical resection of localized renal tumours in our population.

Implications of miscoding urological procedures in an era of financial austerity - 'Every Penny Counts'.

Objectives: The study aimed to find out any inaccuracy in coding of elective urology procedures and associated financial implications.

Design: Retrospective audit and re-audit.

Settings: Introduction of payment by results was introduced in the NHS in England in 2002.

A single United Kingdom center experience of open partial nephrectomy using regional ischemia.

Introduction: Different techniques are used in open partial nephrectomy (OPN) for localized renal cancer, with variable impact on renal function. Regional renal ischemia technique by using different clamps and without the need to occlude renal vessels is gaining popularity. In our study, we present the largest international series; and the first in the United Kingdom; describing OPN using soft bowel clamp.

Expression of the cancer-testis antigen BORIS correlates with prostate cancer.

Background: BORIS, a paralogue of the transcription factor CTCF, is a member of the cancer-testis antigen (CT) family. BORIS is normally present at high levels in the testis; however it is aberrantly expressed in various tumors and cancer cell lines. The main objectives of this study were to investigate BORIS expression together with sub-cellular localization in both prostate cell lines and tumor tissues, and assess correlations between BORIS and clinical/pathological characteristics.